CIK 0001598646 · Non-accelerated filer<br>Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 260784194
- Phone
- 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-28 | Race Geoff President | Grant or award | +46,987 | 73,406 | ||
| 2023-04-28 | Ahlholm Frederick W SVP, CFO and Secretary | Grant or award | +19,843 | 21,098 | ||
| 2022-12-13 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-12-13 | Race Geoff President | Grant or award · Employee Stock Option (right to buy) | +38,000 | 38,000 | ||
| 2022-12-13 | Ahlholm Frederick W SVP, CFO and Secretary | Grant or award · Employee Stock Option (right to buy) | +26,000 | 26,000 | ||
| 2022-06-10 | HILLEMAN JERYL L Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2022-06-10 | DOYLE WILLIAM F Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2022-06-10 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2022-06-10 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2022-06-10 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2022-06-10 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2022-02-16 | Ahlholm Frederick W CFO | Grant or award · Employee Stock Option (right to buy) | +180,000 | 180,000 | ||
| 2022-02-16 | Race Geoff President | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-02-16 | Luthringer Remy CEO | Grant or award · Employee Stock Option (right to buy) | +505,000 | 505,000 | ||
| 2021-12-01 | Kupfer David Director | Sale | −55,635 | $0.88 | $49K | 163,553 |
| 2021-06-11 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-11 | DOYLE WILLIAM F Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2021-06-11 | VAN HEEK G JAN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-11 | HILLEMAN JERYL L Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2021-06-11 | Laghrissi-Thode Fouzia Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 3 of 6 · 120 trades